"Reply to Letter to the Editor on Mease et al." by Philip Mease

Selected Works of Philip Mease, MD

Follow Contact

Article

Reply to Letter to the Editor on Mease et al.

Arthritis Rheumatol

Philip Mease, Swedish Medical Center/Providence St. Joseph Health and the University of Washington, Seattle, Washington, USA
David H Collier
Gregory Kricorian
James B Chung

Link

Document Type

Article

Publication Date

4-7-2020

Disciplines

Orthopedics and
Rheumatology

Abstract

We read with interest the Letter to the Editor by Kerschbaumer et al regarding our article on the primary results from the SEAM-PsA trial (1). We appreciated the comments highlighting the methotrexate (MTX) monotherapy results. Since MTX is a drug that has been long used in psoriatic arthritis (PsA) without much data from rigorous and well-controlled clinical trials, we sought to provide reliable data about MTX through SEAM-PsA.

Clinical Institute

Orthopedics & Sports Medicine

Specialty

Rheumatology

Citation Information

Philip Mease, David H Collier, Gregory Kricorian and James B Chung. "Reply to Letter to the Editor on Mease et al." Arthritis Rheumatol (2020)
Available at: http://works.bepress.com/philip-mease/448/